Filing Details
- Accession Number:
- 0001651844-17-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-07 16:34:16
- Reporting Period:
- 2017-07-05
- Filing Date:
- 2017-07-07
- Accepted Time:
- 2017-07-07 16:34:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-05 | 500 | $3.94 | 3,046,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-05 | 1,000 | $3.95 | 3,047,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-05 | 2,000 | $3.97 | 3,049,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-05 | 1,500 | $3.99 | 3,051,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-06 | 500 | $3.91 | 3,051,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-06 | 1,000 | $3.92 | 3,052,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-06 | 1,500 | $3.93 | 3,054,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-07 | 1,000 | $4.09 | 3,055,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-07-07 | 2,500 | $4.13 | 3,057,550 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
| Common Stock | 49,550 | Indirect | Trust |
Billionaire Hedge Funds
